Title:
POLYETHYLENE GLYCOL MODIFICATIONS OF THYMOSIN ALPHA-1
Document Type and Number:
WIPO Patent Application WO/2007/054030
Kind Code:
A1
Abstract:
Polyethylene glycol modifications of thymosin alpha-1 (Tα1-PEGs), their
preparation process, the medicine composition containing them, and their application
in the medicine for preventing and treating diseases related with immune deficiency
and hypoimmunity, including hepatitis B, hepatitis C, hepatoma, malignant
melanoma, non-small cell lung carcinoma, SARS, and AIDS etc.
More Like This:
Inventors:
LIU KELIANG (CN)
XI JIANKUN (CN)
MA JINBO (CN)
ZHENG JIANQUAN (CN)
DONG SIJIAN (CN)
ZHOU WENXIA (CN)
QI CHUNHUI (CN)
XI JIANKUN (CN)
MA JINBO (CN)
ZHENG JIANQUAN (CN)
DONG SIJIAN (CN)
ZHOU WENXIA (CN)
QI CHUNHUI (CN)
Application Number:
PCT/CN2006/003021
Publication Date:
May 18, 2007
Filing Date:
November 10, 2006
Export Citation:
Assignee:
INST PHARM & TOXICOLOGY AMMS (CN)
LIU KELIANG (CN)
XI JIANKUN (CN)
MA JINBO (CN)
ZHENG JIANQUAN (CN)
DONG SIJIAN (CN)
ZHOU WENXIA (CN)
QI CHUNHUI (CN)
LIU KELIANG (CN)
XI JIANKUN (CN)
MA JINBO (CN)
ZHENG JIANQUAN (CN)
DONG SIJIAN (CN)
ZHOU WENXIA (CN)
QI CHUNHUI (CN)
International Classes:
C07K17/08; A61K38/22; A61K38/32; A61P1/16; A61P31/12; A61P35/00; C07K14/575; C07K14/66
Domestic Patent References:
| WO2003037272A2 | 2003-05-08 |
Foreign References:
| CN1532207A | 2004-09-29 | |||
| CN1690079A | 2005-11-02 |
Attorney, Agent or Firm:
CCPIT PATENT AND TRADEMARK LAW OFFICE (2 Fuchengmenwai Street, Beijing 7, CN)
Download PDF: